Company Active LTD

Company profile

Sectra Limited

Welcome to Sectra Medical imaging IT & Cybersecurity | Sectra Group

Our vision is to contribute to a healthier and safer society. Sectra successfully develops and sells cutting-edge solutions in the expanding niche segments of medical IT and cybersecuritya combination that makes us unique.

CRN
04571654
Founded
2002
Age
23

Overview

Legal name
SECTRA LIMITED
Region
East of England
Registered address
BANK HOUSE
PRIMETT ROAD
STEVENAGE
HERTFORDSHIRE
ENGLAND
SG1 3EE
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

07 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

24 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

28 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MTA4NzY3OGFkaXF6a2N4

Published 28 Oct 2024 10:01

24 Oct
2002

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2019
Funded years
2019, 2020
Age at first award
16 years

Projects

2020 Collaborative R&D

Integrated Diagnostics for Early Diagnosis of Liver Disease [ID-LIVER]

1 Sep 2020 to 31 Aug 2023

Awarded
£0
Total cost £2,655

Liver disease is an epidemic with up to four in ten people having health problems from their liver not working properly. A proportion of these patients develop scarring that is most commonly picked up late but which can progress without stopping to complete liver failure. It is one of the UK's largest health challenges for which we do not have answers. At...

2019 Collaborative R&D

NPIC: National Pathology Imaging Co-Operative

1 Feb 2019 to 31 Mar 2023

Awarded
£653,963
Total cost £1,629,859

"Pathologists are the **doctors who diagnose disease**. To do this, we examine samples (""biopsies"") using a microscope, to decide if a sample shows cancer, and what type of cancer it is. New scanners allow us to create digital images of microscope slides, so we can look at them on computers, and share them between hospitals more easily. This is called *...

Product types

Collaborative R&D